B O O K - American College of Rheumatology

ACR Study Groups
1:00 - 2:00 PM
B309
Capillaroscopy in Rheumatic Diseases
Moderators: Maurizio E. Cutolo, MD; University of Genova;
Genova, Italy
Ariane L. Herrick, MD; Rheumatic Diseases Centre; Trust Salford,
United Kingdom
1:00 PM
Introduction with Brief History of Capillaroscopy
Maurizio E. Cutolo, MD; University of Genova; Genova, Italy
1:05 PM
The Technique of Videocapillaroscopy
Alberto Sulli, MD; University of Genoa, Italy
1:20 PM
Quantification of Microcirculatory Abnormalities using
Capillaroscopy
Ariane L. Herrick, MD; Rheumatic Diseases Centre; Trust Salford,
United Kingdom
1:30 PM
Capillaroscopic Patterns: From Normal to Pathologic
Maurizio E. Cutolo, MD; University of Genova; Genova, Italy
1:40 PM
Discussion
1:45 PM
Practical ‘Live’ Demonstration of Videocapillaroscopy
Ariane L. Herrick, MD; Rheumatic Diseases Centre; Trust Salford,
United Kingdom
Maurizio E. Cutolo, MD; University of Genova; Genova, Italy
Session Overview:
Nailfold capillaroscopy provides a unique and noninvasive/
safe window into the microcirculation, and abnormal nailfold
capillaries are highly predictive of an underlying connective
tissue disorder. Typical changes include widened capillaries
and areas of avascularity. Recent advances in capillaroscopy,
including videocapillaroscopy (which allows high magnification)
and computerised software, are revitalizing interest in
capillaroscopy amongst rheumatologists. The ability to
quantify abnormality means that capillaroscopy has the
potential of becoming an early diagnostic tool and biomarker
in scleroderma-spectrum disorders. A study group will inform
attendees of these advances and stimulate the international
dialogue necessary to standardize techniques and further
broaden their clinical application.
Upon completion of this session, participants should be able to:
• discuss advantages and disadvantages of different
capillaroscopy methods (dermoscopy, widefield
capillaroscopy, videocapillaroscopy)
• describe major capillaroscopic abnormalities suggestive of a
scleroderma-spectrum disorder and score them
• identify current and future clinical and research applications
B308
Childhood Vasculitis
Moderators: Susanne M. Benseler, MD, PhD; The Hospital for
Sick Children; Toronto, ON, Canada
David A. Cabral, MBBS; British Columbia Children’s Hospital;
Vancouver, BC, Canada
1:00 PM
Novel Approaches to Classifying Systemic Childhood Vasculitis
David A. Cabral, MBBS; BC Children’s Hospital; Vancouver, BC,
Canada
1:15 PM
Novel Biomarkers of Childhood Vasculitis
Paul Brogan, BSc, MBCHB, PhD; Rheumatology Unit, Institute of
Child Health; London
1:30 PM
Disease Activity in Childhood Vasculitis
Pavla Dolezalova, MD; 1st Faculty of Medicine and General
Faculty Hospital; Praha, Czech Republic
1:45 PM
Measurement and Study Conduct in Childhood Vasculitis
Raashid Luqmani, DM; Nuffield Department of Orthopaedics,
Rheumatology and Musculoskeletal Sciences; Oxford, United
Kingdom
Session Overview:
Successful international collaboration and the development
of innovative, web-based data collection tools have recently
advanced the field of childhood vasculitis. The international
pediatric vasculitis investigator network was established,
which is currently conducting important studies aiming to
enhance disease recognition, validate classification proposals,
develop and validate measures of disease activity and damage,
standardize treatment protocols and ultimately improve the
outcome of children with vasculitis worldwide. The study group
application aims to formalize the strong association of the
investigators with the ACR. The focus of the first study group
session is classification and diagnostic challenges of childhood
vasculitis.
Upon completion of this session, participants should be able to:
• recognize distinct entities in the spectrum of childhood
vasculitis
• classify pediatric vasculitis patients based on the newly
validated classification system
• identify novel biomarkers of childhood vasculitis
• assess disease activity of pediatric vasculitis patients using the
novel PVAS tool
B311
Clinical Research Methodology
Moderator: Theodore Pincus, MD; New York University Hospital
for Joint Disease; Hastings-on-Hudson, NY
1:00 PM
Improved Outcome Criteria for Rheumatic Diseases: The Role
of IRT and CAT
James F. Fries, MD; Stanford University Medical Center; Palo
Alto, CA
1:20 PM
Diagnostic Criteria for Rheumatoid Arthritis - The New and The
Old
Yusuf Yazici, MD; Hospital for Joint Diseases; Hastings on
Hudson, NY
2010 Program Book 107
wednesday